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n axonal complex of cell adhesion molecules con-
sisting of Caspr and contactin has been found to be
essential for the generation of the paranodal axo-glial
junctions ﬂanking the nodes of Ranvier. Here we report that
although the extracellular region of Caspr was sufﬁcient for
directing it to the paranodes in transgenic mice, retention
of the Caspr–contactin complex at the junction depended
on the presence of an intact cytoplasmic domain of Caspr.
Using immunoelectron microscopy, we found that a Caspr
mutant lacking its intracellular domain was often found
within the axon instead of the junctional axolemma. We
A
 
further show that a short sequence in the cytoplasmic domain
of Caspr mediated its binding to the cytoskeleton-associated
protein 4.1B. Clustering of contactin on the cell surface
induced coclustering of Caspr and immobilized protein
4.1B at the plasma membrane. Furthermore, deletion of the
protein 4.1B binding site accelerated the internalization of
a Caspr–contactin chimera from the cell surface. These results
suggest that Caspr serves as a “transmembrane scaffold” that
stabilizes the Caspr/contactin adhesion complex at the para-
nodal junction by connecting it to cytoskeletal components
within the axon.
 
Introduction
 
The reciprocal interactions between neurons and glial cells
are essential for the coordinated differentiation of ax-
ons and myelin-forming cells, which allow myelinating fi-
bers to maximize their conduction velocity (Arroyo and
Scherer, 2000; Peles and Salzer, 2000). The closest contact
site between the axon and its myelinating Schwann cells or
oligodendrocytes is found at the paranodal region that
flanks the node of Ranvier. At this site, the cytoplasmic
loops of the myelinating cell create a septate-like junction
with the axon, which separates the electrical activity at the
nodes of Ranvier from the internodal region that lies under
the compact myelin sheath (Wiley and Ellisman, 1980;
Rosenbluth, 1995). Three cell adhesion molecules have
been identified thus far at the paranodes of both the peripheral
nervous system (PNS)* and central nervous system (CNS).
These include an axonal complex that consists of Caspr
(contactin-associated protein, also known as Paranodin) and
the GPI-linked protein contactin (Einheber et al., 1997;
Menegoz et al., 1997; Peles et al., 1997; Rios et al., 2000),
which binds to an isoform of neurofascin (NF155) present
on the glial loops (Tait et al., 2000; Charles et al., 2002).
Both Caspr and contactin are essential for the generation
of the paranodal junction, and their absence results in the
disappearance of the transverse bands, which are the hallmark
of this axo-glial contact (Bhat et al., 2001; Boyle et al., 2001).
The generation and maintenance of neuronal polarity
is achieved through specific sorting mechanisms that are
followed by anchoring and clustering of various mem-
brane proteins to distinct domains (Winckler and Mellman,
1999). In myelinated fibers, the location of such domains
is controlled by the ensheathing glial cell and by intrinsic
determinants within the axon (Ellisman, 1979; Deerinck
et al., 1997; Kaplan et al., 1997; Lambert et al., 1997;
Waxman, 1997; Vabnick and Shrager, 1998; Bennett and
Lambert, 1999; Peles and Salzer, 2000; Rasband and
Shrager, 2000). The localization of Caspr during the gen-
eration of the paranodal junction may be mediated by its
interaction with both a glial ligand and cytoplasmic com-
ponents within the axon (Peles and Salzer, 2000; Rios et
al., 2000; Pedraza et al., 2001). The presence of Caspr at
the paranodes and the juxtamesaxon (Menegoz et al.,
1997; Arroyo et al., 1999), as well as its appearance in a
spiral below the overlying turn of the paranodal loops
that forms during development (Pedraza et al., 2001),
strongly suggests that its localization in the axon is regulated
by the overlying myelin sheath. The extracellular region
of Caspr binds laterally to contactin when both proteins
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are expressed in the same cell (i.e., cis interactions; Peles
et al., 1997), generating a receptor complex that binds neu-
rofascin (Volkmer et al., 1998; Charles et al., 2002). The in-
teraction with contactin is required for an efficient export of
Caspr from the endoplasmic reticulum and its transport to
the plasma membrane in transfected cells (Faivre-Sarrailh et
al., 2000). In agreement, in contactin-null mice, Caspr is re-
tained within neuronal cell bodies, demonstrating that con-
tactin is essential for axonal sorting of Caspr (Boyle et al.,
2001). Furthermore, contactin is absent from the paranodal
junction in mice lacking Caspr (Bhat et al., 2001), suggest-
ing that the localization of both proteins at this site is inter-
dependent. Similarly, disruption of the paranodal junction
in galactolipid-deficient mice results in the disappearance of
both proteins from the paranodes (Dupree et al., 1999; Po-
liak et al., 2001). The absence of contactin from the paran-
odal junction in mice lacking Caspr may suggest that the lat-
ter is required to anchor the Caspr–contactin complex to the
axonal cytoskeleton at this site. A candidate protein that may
connect Caspr to the axonal cytoskeleton at the paranodes is
4.1B, a member of the protein 4.1 family, which links
membrane proteins with the actin/spectrin cytoskeleton
(Baumgartner et al., 1996; Menegoz et al., 1997; Hoover
and Bryant, 2000) and is found at the axonal paranodes and
juxtaparanodal region (Ohara et al., 2000; Poliak et al.,
2001).
In this study we used transgenic mice expressing a deletion
mutant of Caspr lacking its cytoplasmic region to examine
the mechanisms involved in the localization of the Caspr–
contactin complex at the paranodal junction. Our results
suggest that although the extracellular region of Caspr is suf-
ficient to direct it to the paranodal junction, retention of the
Caspr–contactin complex at this site requires the intracellu-
lar domain of Caspr, which may link it to the axonal cyto-
skeleton through protein 4.1B.
 
Results
 
Generation of transgenic mice expressing a deletion 
mutant of Caspr in neurons
 
During myelination, Caspr is targeted to the paranodal
junctions, located at both sides of the node of Ranvier. To
determine whether the intracellular region of Caspr contains
signals involved in its localization at the paranodal junctions,
we have constructed a deletion mutant in which this domain
was replaced with a hemagglutinin tag (CSPdCT–HA; Fig.
1). As a control, we have generated a tagged version of Caspr
(CSP–HA) by fusing the HA tag at the carboxy terminus of
the molecule. The presence of the HA tag in these constructs
enables a clear distinction between the endogenous and the
expressed proteins. The expression of these constructs in
transfected HEK-293 cells could be detected using an HA
tag antibody as well as an antibody directed against the ex-
tracellular domain (i.e., CSP–HA and CSPdCT–HA); an
antibody against Caspr’s intracellular region recognized
CSP–HA but not CSPdCT–HA (Fig. 1). We next examined
the ability of the tagged proteins to associate with contactin,
as this interaction was previously shown to be required for
surface expression and axonal transport of Caspr (Faivre-Sar-
railh et al., 2000; Boyle et al., 2001). As shown in Fig. 1 C,
when coexpressed in HEK-293 cells, both CSP–HA and
CSPdCT–HA formed a stable complex with contactin,
which could be immunoprecipitated by an HA tag antibody.
Furthermore, both transgenes were efficiently expressed on
the cell surface, as was evident by staining the cells with a
monoclonal antibody that recognized the extracellular do-
main of Caspr in intact cells (Fig. 1 D), as well as by surface
biotinylation experiments (unpublished data).
To direct the expression of these Caspr constructs in neu-
rons, they were placed under the transcription regulatory ele-
ments of Thy1.2, a GPI-linked cell surface glycoprotein ex-
pressed in the CNS in peripheral long-projecting neurons,
Figure 1. Structure and expression of Caspr 
constructs. (A) Schematic representation of the 
various Caspr constructs used in this study. In CSP–
HA, an HA tag was added after the last amino acid 
of human Caspr, whereas in CSPdCT–HA, the HA 
tag replaced its cytoplasmic domain. Cyto, cyto-
plasmic region; Disc, discoidin-like domain; EGF, 
EGF repeat; fib, fibrinogen-like domain; LamG, 
laminin G domain; PGY, a proline/glycine/tyrosine-
rich region; TM, transmembrane domain. 
(B) Expression of Caspr constructs in transfected 
cells. Sample of cell lysates prepared from parental 
HEK-293 (none), or cells transfected with CSP–HA 
(HA), CSPdCT–HA (dCT-HA), or human Caspr 
were used for immunoprecipitation and immunoblot 
analyses using anti-Caspr (top) or anti-HA antibody 
(bottom). Note that the anti-Caspr antibody used is 
directed against the cytoplasmic tail of the protein 
and therefore does not recognize CSPdCT–HA, 
which was detected by the HA antibody. Mol wt 
markers in kD are shown on the right. (C) Coim-
munoprecipitation of contactin and Caspr mutants. HEK-293 cells were transfected with contactin alone (293), or together with CSP–HA (HA) 
or CSPdCT–HA (dCT) as indicated. Immunoprecipitation was performed with an antibody to HA tag (HA) or to contactin (Con) as indicated 
on the right of each panel (IP), followed by immunoblotting with anticontactin antibody. (D) Cell surface expression of Caspr constructs in 
transfected COS7 cells. Cells were transfected with contactin and CSP–HA or CSPdCT–HA as indicated on the top. Cells were fixed and 
stained with an antibody against the extracellular region (ECD) or an HA tag antibody found in the intracellular region of each Caspr construct 
(Cyto), with ( ) or without ( ) prior permeabilization (TX). The nuclei of the cells were labeled with DAPI (blue). 
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thymus, and fibroblasts (Gordon et al., 1987). The expression
cassette used in the present study contained a deletion in the
third intron of the Thy1.2 gene, restricting the expression of
the transgenes to the nervous system (Caroni, 1997; Feng et
al., 2000). An important advantage of this system is that the
expression of the transgene starts around postnatal day 6, al-
lowing the investigation of relatively late events, such as my-
elination, without interfering with the early stages of nervous
system development. All constructs were derived from the hu-
man Caspr gene in order to facilitate the detection of the trans-
gene in the progenies. As depicted in Fig. 2, the expression of
both transcripts and proteins of the two tagged molecules were
detected in brains of the transgenic mice. When compared
with the endogenous Caspr protein by immunobloting, the ex-
pression levels of the transgenes were lower and varied from 20
to 30% for CSPdCT–HA and CSP–HA, respectively. Similar
levels of the transgenes were detected in several lines of trans-
genic mice that were generated for each construct (unpub-
lished data). In the CNS, the transgenes had first been detected
at postnatal day 5 and their level increased further as develop-
ment proceeded until they reached their maximum levels in
the adult (Fig. 2 C; unpublished data). Thus, the expression of
the transgenes occurs concomitantly with the time endogenous
Caspr was first detected in the paranodes (Rasband et al.,
1999). As observed in transfected cells (Fig. 1 C), contactin
could be coimmunoprecipitated using an anti-HA antibody
from brain lysates prepared from the transgenic animals, but
not from a wild-type mouse. These results demonstrate that
 
both CSPdCT–HA and CSP–HA are associated with contac-
tin in vivo as the endogenous Caspr protein (Fig. 2 D).
 
Localization of Caspr transgenes in myelinated fibers in 
the PNS and CNS
 
We next examined the localization of the expressed proteins
along the sciatic nerve. As depicted in Fig. 3, double labeling of
teased fiber preparations using Na
 
 
 
 channels and HA tag anti-
bodies revealed that both the full-length version of Caspr
(CSP–HA) and the mutant lacking the cytoplasmic domain
(CSPdCT–HA) were found in the paranodes. No staining was
observed using an HA tag antibody in wild-type nerves. In ad-
dition, normal paranodal localization of the endogenous Caspr
was observed in all the examined fibers from these transgenic
animals. A similar pattern was also found in the CNS (Fig. 4).
Staining of optic nerve sections from wild-type and transgenic
mice with an antibody to Caspr revealed a normal intermittent
staining surrounding the nodes of Ranvier. Paranodal labeling
of the HA tag was observed in optic nerves derived from CSP–
HA and CSPdCT–HA but not from wild-type control ani-
mals (Fig. 4, A–C). Double labeling for HA tag and Caspr
showed that CSP–HA and CSPdCT–HA transgenes were
found only in part of the axons. Such variation of transgene ex-
pression using the Thy1 promoter is well documented (Ca-
roni, 1997) and results from stochastic expression of the trans-
gene in a subset of retinal ganglion cells (Feng et al., 2000).
Altogether, these experiments demonstrated that the intracel-
lular region of Caspr is not essential for proper targeting of the
protein to the paranodal junction in myelinated axons.
 
Retention of the Caspr–contactin complex at the 
paranodes requires the cytoplasmic tail of Caspr
 
To further determine whether the transgenes were properly lo-
cated at the paranodal septate-like junctions at the ultrastruc-
tural level, we examined their localization in optic nerves using
immunoelectron microscopy. In cross sections at the level of
the paranodes of wild-type and CSPdCT–HA mice, staining
with an antibody against the intracellular region of Caspr,
Figure 2. Expression of Caspr mutants in transgenic mice. 
(A) RT-PCR analyses. RNA was isolated from brains of adult transgenic 
animals expressing CSPdCT–HA (dCT–HA) or CSP–HA (HA) or 
control mice and used as a template for RT-PCR analysis using a 
primer set that recognizes CSP–HA and CSPdCT–HA. Plasmid 
templates containing the various mutants were used as specificity 
controls. (B) Protein expression of Caspr transgenes in adult mice 
brains. Brain membrane lysates from wild-type (WT) and the two 
Caspr transgenic mice were subjected to immunoprecipitation and 
immunoblotting using an antibody against Caspr or HA tag as 
indicated at the bottom of each panel. The immunoblots are shown 
along with mol wt markers in kD on the right. (C) Expression of 
Caspr and CSPdCT–HA during development. Brain membrane 
proteins were prepared from CSPdCT–HA mice at different postnatal 
days as indicated and subjected to immunoblot analyses with 
antibody to Caspr (top) or HA tag (bottom). (D) Interaction of Caspr 
transgenes with contactin in mouse brain. Brain lysates of wild-type 
(WT), CSP–HA (HA), or CSPdCT–HA (dCT) mice were subjected to 
immunoprecipitation with an antibody to HA tag (HA), Caspr, or 
contactin (Con) as indicated on the left of each panel. The resulted 
complexes were immunoblotted with an anticontactin antibody.
Figure 3. Localization of Caspr transgenes in peripheral nerve. 
Teased sciatic nerves from adult wild-type (WT) or the two transgenic 
mice (as indicated on top of the figure) were double labeled with an 
antibody against Na
  channel (red) and with either Caspr (green, top) 
or HA tag (green, bottom). Paranodal localization of the transgenes was 
detected in all the axons that expressed the transgenes. Bar, 10  m. 
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which only recognizes the endogenous protein, resulted in a
circumferential labeling surrounding the axon (Fig. 5, A and
B). A similar staining pattern was obtained in optic nerves
from CSP–HA mice labeled with an HA tag antibody (Fig. 5
C). In contrast, specific labeling of optic nerves from CSP-
dCT–HA animals using an antibody to HA tag was frequently
detected within the axon (Fig. 5 D). At these sites, the gold
particles were occasionally surrounded by a membrane config-
uration that was better detected by carefully tilting the sample.
In favorable planes of the section, the staining was clearly ob-
served within a vesicular structure (Fig. 5 F, inset). We then re-
peated the same analysis using longitudinal sections of optic
nerves from the different transgenic animals. As expected, the
endogenous protein was clearly detected at the axonal mem-
brane in optic nerve sections from wild-type mouse (Fig. 5 E).
Similar staining was also revealed using an HA tag antibody on
optic nerve sections from CSP–HA (unpublished data). In
contrast, in CSPdCT–HA mice, HA tag labeling was not con-
fined to the axolemma, and was also located within the axon
(Fig. 5, F and G). As summarized in Table I, internal distribu-
tion of the gold particles of HA-labeled nerves was found in
76.9% of the sections examined in CSPdCT–HA, compared
with only 5.3% in CSP–HA. The latter was comparable to the
6.6% of internal labeling of Caspr detected in wild-type
nerves. Importantly, staining of CSPdCT–HA at the axonal
circumference was observed in 66% of the sections, demon-
strating that this mutant was still residually found at the para-
nodal junction. The presence of CSPdCT–HA molecules
within the axon may result from its reduced insertion into the
axolemma, or alternatively from its destabilization and inter-
nalization due to the inability of this mutant to interact with
cytoskeletal components at the paranodal junction.
Because CSPdCT–HA was associated with contactin sim-
ilarly to a wild-type Caspr (Fig. 1 C and Fig. 2 D), we exam-
ined whether the mislocalization of this mutant within the
axon may also affect the subcellular localization of contactin.
Whereas contactin was detected at the axonal circumference
in optic nerve from wild-type and CSP–HA mice (Fig. 5, H
and I), in optic nerves derived from CSPdCT–HA animals,
it was less confined to the axonal circumference and was oc-
casionally seen within the axon (Fig. 5, J and K). Altogether,
these results suggest that although the extracellular region of
Caspr is sufficient to direct it to the paranodes, its cytoplas-
mic domain is required for retention of the Caspr–contactin
complex at the paranodal junction.
 
The cytoplasmic region of Caspr is required for binding 
and immobilization of protein 4.1B
 
Our results so far suggest that the maintenance of the Caspr–
contactin complex at the paranodal junction may require its
linkage to the axonal cytoskeleton through the cytoplasmic do-
Figure 4. Immunolocalization of Caspr transgenes in CNS white 
matter. Sections of adult optic nerves from wild-type (A, D, and G), 
CSP–HA (B, E, and H), and CSPdCT–HA mice (C, F, and I) were 
double labeled with an antibody to Na
  channel (red) and HA tag 
(green; A–C), Na
  channel (red) and Caspr (green; D–F), or HA tag 
(red) and Caspr (green; G–I). Bar, 10  m. Note that Caspr transgenes 
were not expressed in all retinal ganglion cells and thus were only 
found in 30–40% of the paranodes as detected by a Caspr antibody 
(D–F, yellow).
Figure 5. Immunoelectron microscopy 
localization of Caspr transgenes and contactin in 
optic nerve. Immunogold labeling of Caspr in 
cross sections at the paranodal level of optic 
nerves from adult wild type (A) or CSPdCT–HA (B). 
Similar sections were labeled with HA tag antibody 
in optic nerve from CSP–HA (C) or CSPdCT–HA 
(D) animals. Longitudinal sections at nodal regions 
of optic nerve from wild type labeled for Caspr (E) 
or from CSPdCT–HA mice labeled for HA tag 
(F and G). Note that in both cross and longitudinal 
sections, whereas the endogenous Caspr or HA tag 
in CSP–HA animals was confined to the inner 
surface of the axonal membrane in the paranodes, 
HA tag labeling in CSPdCT–HA mice was observed 
in the axonal cytoplasm at the paranodes. At a 
higher magnification, HA tag staining in optic 
nerves from CSPdCT–HA mice was clearly detected 
in vesicular structures (F, inset). Labeling of contactin 
in cross sections of optic nerve from wild-type (H), 
CSP–HA (I), or CSPdCT–HA mice (J–K). Bars, 0.2 
 m (except for inset, which is 0.02  m). 
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main of Caspr. Such function may be provided by protein 4.1B
that is concentrated at the axonal paranodal and juxtaparanodal
regions (Ohara et al., 2000; Poliak et al., 2001). To explore this
possibility, we performed pulldown and coimmunoprecipita-
tion experiments to examine whether 4.1B interacts with
Caspr. As depicted in Fig. 6 A, glutathione-
 
S
 
-transferase (GST)
fusion protein containing the cytoplasmic domain of Caspr, but
not GST alone, pulled down protein 4.1B from HEK-293 cells
expressing this protein. Protein 4.1B could also be coimmuno-
precipitated using two different antibodies to Caspr from rat
brain lysate (Fig. 6 B). Furthermore, protein 4.1B was associ-
ated with CSP–HA but not CSPdCT–HA (Fig. 6 C), demon-
strating that the intracellular domain of Caspr mediates its
association with protein 4.1B. We next examined whether
clustering of the Caspr–contactin complex at the plasma mem-
brane could affect the localization of protein 4.1B. To induce
clustering of this complex, we used an Fc fusion protein con-
taining the carbonic anhydrase domain of RPTP
 
 
 
 (
 
 
 
C–Fc),
previously shown to bind contactin (Peles et al., 1995). As
shown in Fig. 6 D, expression of CSPdCT–HA, contactin, and
protein 4.1B at the plasma membrane was detected in HeLa
cells coexpressing these proteins. As expected, binding of 
 
 
 
C–
Fc to these cells, without allowing clustering to occur, resulted
in an identical pattern to that obtained using a contactin anti-
body (Fig. 6 D, compare the second and fourth panels) or an
antibody against Caspr (unpublished data). Clustering of 
 
 
 
C–
Fc fusion protein on cells expressing protein 4.1B, contactin,
and either CSP–HA or CSPdCT–HA resulted in aggregation
of contactin and the tagged Caspr molecules (Fig. 6 E). In con-
trast, protein 4.1B was incorporated into these clusters when
coexpressed with CSP–HA but not with CSPdCT–HA.
To further analyze whether the interaction of Caspr with
protein 4.1B affected the stabilization of Caspr on the cell
 
Table I. 
 
Quantitation of the distribution of Caspr transgenes at the 
paranodal region by immunoelectron microscopy
Mouse/Ab Internal Circumference
 
WT/Caspr 6.6% (3/45) 100% (45/45)
CSP–HA/HA 5.3% (1/19) 100% (19/19)
CSPdCT–HA/HA 76.9% (30/39) 66% (24/39)
Cross sections of optic nerves at the paranodal level from wild-type mice
stained for Caspr, or CSP–HA and CSPdCT–HA stained with an antibody to
HA tag (mouse/Ab) were analyzed. The presence of the gold particles
within the axon (internal) or at the axolemma (circumference) was scored.
Results are shown as a percentage of the sections examined along with the
total numbers analyzed in parentheses. This quantitation demonstrates that
although Caspr and CSP–HA are predominantly concentrated at the
paranodal junction, CSPdCT–HA is found in both the paranodal junction
and within the cytoplasm.
Figure 6. Interaction of Caspr with protein 4.1B. (A) Pulldown of protein 4.1B by the cytoplasmic domain of Caspr. Lysates of HEK-293 
cells expressing protein 4.1B were mixed with agarose-bound GST or GST fusion protein containing the cytoplasmic domain of Caspr as 
indicated. Bound proteins were immunoblotted with an antibody to protein 4.1B. Immunoprecipitation with an antibody to protein 4.1B 
(4.1B) was used as a control. (B) Coimmunoprecipitation of protein 4.1B with Caspr from rat brain. Adult rat brain lysates were subjected to 
immunoprecipitation with antibodies to protein 4.1B (4.1B) or the cytoplasmic (Caspr/CT) or extracellular (Caspr/ECD) domains of Caspr as 
indicated. Preimmune serum (CS) or protein A beads (beads) were used as controls. (C) Association of protein 4.1B with CSP–HA, but not 
with CSPdCT–HA. HEK-293 cells were transfected with CSP–HA or CSPdCT–HA, with ( m4.1B) or without myc-tagged protein 4.1B as 
indicated on the top. Cell lysates were subjected to immunoprecipitation with an antibody against the extracellular domain of Caspr. Washed 
immune complexes were separated on SDS gel and immunoblotted with an antibody to myc (right) or HA tag (left). The sizes of mol wt markers 
are shown on the right in kD. (D) Binding of  C–Fc fusion protein under nonclustering conditions. Hela cells expressing CSPdCT–HA, contactin, 
and protein 4.1B were stained with the indicated antibodies or with  C–Fc fusion protein. The second and fourth panels show the same cell 
stained for contactin and the  C–Fc fusion protein. (E) Clustering of CSP–HA, but not CSPdCT–HA, induces aggregation of protein 4.1B. Hela 
cells expressing contactin, protein 4.1B, and CSP–HA (HA) or CSPdCT–HA (dCT), as indicted on the bottom of each column, were allowed to 
bind  C–Fc followed by clustering with Cy3-conjugated anti–human Fc antibody. Cells were stained with an antibody to Caspr, contactin, or 
protein 4.1B as indicated in the upper row. The distribution of the clustered  C–Fc fusion protein and the merged images ( C–Fc, red; antibody 
staining, green) are shown in the middle and lower rows, respectively. Note that although  C-Fc induced clustering of contactin, CSP–HA, 
and CSPdCT-HA, immobilization of protein 4.1B into these clusters occurred in CSP–HA- but not in CSPdCT–HA-expressing cells. 
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surface, we constructed two chimeric proteins in which the
transmembrane and cytoplasmic domain of Caspr (ConCT)
or a deletion mutant lacking nine amino acids in its jux-
tamembrane region (ConJXCT) were fused to the extracel-
lular domain of contactin (Fig. 7 A). The latter was con-
structed based on the observation that the juxtamembrane
region of Caspr contains a putative binding site for members
of the protein 4.1 family (Menegoz et al., 1997; Peles et al.,
1997; Hoover and Bryant, 2000). These chimeras were effi-
ciently expressed on the cell surface, thus resulting in the tar-
geting of the cytoplasmic domain of Caspr to the plasma
membrane (Fig. 7 B). However, only ConCT, not Con-
JXCT, formed a complex with protein 4.1B (Fig. 7 C), and
induced its aggregation at the plasma membrane upon clus-
tering with 
 
 
 
C–Fc (Fig. 7 D), demonstrating that Con-
JXCT lacks the binding site for protein 4.1B. Surface
biotinylation experiments were then used to examine the
internalization of ConCT or ConJXCT from the cell sur-
face. HEK-293 cells expressing protein 4.1B and ConCT or
ConJXCT were biotinylated with the reversible membrane-
impermeable reagent sulfo-NHS-
 
S
 
-
 
S
 
-biotin and then trans-
ferred to 37
 
 
 
C in medium containing 
 
 
 
C–Fc to allow inter-
nalization. The remaining biotinylated proteins on the cell
surface were removed with glutathione, and internalized
proteins were precipitated using immobilized avidin and an-
alyzed by immunoblotting with an HA tag antibody. As de-
picted in Fig. 7 E, during the first 20 min of incubation at
37
 
 
 
C, 
 
 
 
10% of the labeled ConJXCT was internalized. In
contrast, ConCT was not detected within the cell during
this time, suggesting that the interaction with protein 4.1B
stabilized the expression of this chimera on the cell surface.
The ability of Caspr to mobilize protein 4.1B at the
plasma membrane raises the possibility that Caspr may re-
cruit 4.1B at the paranodal junction. Thus, to determine
whether the paranodal localization of protein 4.1B depends
on the presence of Caspr, we examined its distribution in
Figure 7. Protein 4.1B binds a short 
sequence at the transmembrane domain 
of Caspr. (A) Schematic representation 
of contactin–Caspr chimeras. ConCT 
contains the extracellular region of 
contactin fused to the transmembrane and 
cytoplasmic domain of Caspr. ConJXCT 
lacks nine amino acids from the 
juxtamembrane domain of Caspr 
(sequence shown in the bottom). Both 
chimeras contain an HA tag at their 
carboxy terminus. (B) Cell surface local-
ization of the chimeras. HEK-293 cells 
expressing ConCT or ConJXCT, as 
indicated on the top, were labeled with 
biotin, lysed, and subjected to immuno-
precipitation with an antibody to HA 
tag. Western blotting was performed 
with an antibody to HA (HA) or HRP-
conjugated streptavidin to detect cell 
surface expression of the chimeras. 
(C) Association of ConCT, but not 
ConJXCT, with protein 4.1B. HEK-293 
cells were transfected with ConCT or 
ConJXCT with ( m4.1B) or without a 
myc-tagged protein 4.1B, as indicated 
on the top. Cells expressing 4.1B alone 
(4.1B) served as an additional control. 
Immunoprecipitation (IP) and immuno-
blotting (blot) were performed with the 
different antibody combinations indicated 
on the left of each panel. The sizes of 
mol wt markers are shown on the right 
in kD. (D) Clustering of protein 4.1B by 
ConCT but not ConJXCT. HeLa cells 
expressing protein 4.1B and ConCT or 
ConJXCT were incubated with  C–Fc, 
with ( ) or without ( ) further clustering 
by anti–human Fc antibody as indicted 
on the left. Staining of the cells with an 
antibody to protein 4.1B (green) and  C–Fc (red) are shown along with the merged images on the right. Protein 4.1B was not incorporated 
into clusters in cells expressing ConJXCT. (E) Internalization of ConCT and ConJXCT from the cell surface during time in culture. HEK-293 
cells expressing equal amounts of protein 4.1B and ConCT (top) or ConJXCT (bottom) were biotinylated using sulfo-NHS-S-S-biotin. Cells 
were then incubated with  C–Fc-containing medium at 37 C for the indicated times to allow internalization of biotinylated surface proteins. 
Cells were placed on ice to stop trafficking and, subsequently, were either treated with glutathione to remove remaining labeled proteins on 
the cell surface (internalized) or were left untreated (total). Biotinylated proteins were precipitated from cell lysates using agarose–streptavidin 
followed by immunoblotting with anti–HA tag antibody. 
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myelinated nerves derived from contactin-deficient mice,
which lack the Caspr–contactin complex at their paranodes
(Boyle et al., 2001). Staining of teased sciatic nerves of
8-d-old wild-type mice revealed that protein 4.1B was con-
centrated at the paranodal junction (Fig. 8). In contrast, in
age-matched nerves derived from contactin-null mice, pro-
tein 4.1 was distributed along the axon. It should be noted
that in peripheral nerves at this age, Caspr is already local-
ized at all paranodes, whereas Caspr2 is only starting to ap-
pear (Poliak et al., 2001). At older ages, paranodal accu-
mulation of protein 4.1B was evident when Caspr2 was
abnormally present at the paranodes instead of the juxta-
paranodal region (unpublished data). Taken together, these
results demonstrate that Caspr binds protein 4.1B through a
short juxtamembrane sequence in its cytoplasmic tail, an as-
sociation that could immobilize protein 4.1B to Caspr–con-
tactin sites at the cell membrane. This in turn serves to stabi-
lize Caspr at the cell surface.
 
Discussion
 
The localization of ion channels and cell adhesion molecules
to distinct domains at and around the nodes of Ranvier is
thought to be regulated by signals provided by the overlying
myelinating glial cells, as well as by cytoplasmic proteins
within the axon (Bennett and Lambert, 1999; Peles and
Salzer, 2000). Caspr and contactin form an adhesion com-
plex that is essential for the generation of the paranodal junc-
tion and, subsequently, for the organization of the nodal area
(Bhat et al., 2001; Boyle et al., 2001). Here we report that al-
though the extracellular region of Caspr was sufficient to di-
rect it to the paranodal region, its cytoplasmic domain was
necessary for retention of the Caspr–contactin complex at the
junction. Ultrastructural analysis revealed that a Caspr mu-
tant lacking its intracellular domain (CSPdCT–HA) was of-
ten found within the axon instead of the junctional axo-
lemma. Notably, the CSPdCT–HA mutant was residually
found at the paranodal junction, indicating that the intracel-
lular region of Caspr is not required for its insertion into the
plasma membrane. This conclusion was also supported by
the observation that, similarly to the wild-type protein, this
mutant efficiently reached the cell surface when coexpressed
with contactin. Furthermore, deletion of a short juxtamem-
brane sequence that serves as a protein 4.1B binding site re-
sulted in faster internalization of a chimeric protein in which
the extracellular region of contactin was fused to the trans-
membrane and cytoplasmic domain of Caspr. Taken to-
gether, the presence of CSPdCT–HA within the axon most
likely results from its instability at the paranodal junction and
its internalization, rather than from its inability to be inserted
into the axonal membrane. At present, it is not clear whether
CSPdCT–HA is trafficked back to the cell body for degrada-
tion or is being recycled back to the plasma membrane.
Caspr and contactin form a lateral complex that is found
at the paranodal junction (Rios et al., 2000). Expression of
the CSPdCT–HA mutant, but not of a full-length Caspr in
transgenic mice, resulted in mislocalization of contactin.
This result suggests that contactin, which is a GPI-linked
protein anchored only to the outer leaflet of the membrane,
depends on lateral association with Caspr to be maintained
at specific sites along the axon. We propose that, after an ini-
tial targeting phase, which requires the extracellular domain
of Caspr and depends on its interaction with contactin, a
second process of stabilization takes place once the complex
is deposited at the paranodes. This process is mediated by
the intracellular domain of Caspr that links the complex to
the axonal cytoskeleton (Fig. 9). This mechanism may well
explain the notable lack of contactin from the paranodal do-
main in Caspr-null mice (Bhat et al., 2001); in the absence
of Caspr, the linkage between contactin and the underlying
axonal cytoskeleton at the paranodal junction is disrupted,
resulting in the disappearance of contactin from this site.
The localization of cell adhesion molecules at cell junctions
depends on their interaction with cytoskeleton-associated
proteins (Knust, 2000; Muller, 2000). Candidate axonal pro-
teins that may be involved in the localization of Caspr at the
paranodal junction are members of the protein 4.1 family,
which link membrane proteins with the actin/spectrin cy-
toskeleton (Hoover and Bryant, 2000; Bennett and Baines,
2001). Four different 4.1 proteins are expressed in the ner-
Figure 8. Abnormal distribution of protein 4.1B in peripheral 
nerves of contactin-deficient mice. Teased sciatic fibers from 8-d-old 
wild-type animals (WT) or mice lacking contactin (Con
 / ) were 
double labeled with antibodies to Na
  channel (red) and protein 
4.1B (green) as indicated in each panel. The merged images are 
shown in the right panels. Note that in contactin
 /  nerves, protein 
4.1B is diffusely distributed along the axon.
Figure 9. Proposed mechanisms involved in the localization of 
Caspr and contactin at the paranodal junction. Localization of 
Caspr at the paranodes involves several molecular interactions. Dur-
ing development of myelinated nerves, the interaction with contactin is 
required for a proper transport of Caspr out of the neuronal cell body. 
This complex is then accumulated at the paranodes probably as a 
result of its interactions with NF155 present on the glial loops. Once 
at the paranodal region, Caspr recruits protein 4.1B, which helps to 
stabilize the Caspr–contactin complex at the paranodal junction by 
linking it to the underlying axonal cytoskeleton. 
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vous system at different subcellular locations (Walensky et
al., 1999; Yamakawa et al., 1999; Parra et al., 2000; Ya-
makawa and Ohara, 2000); one of which (protein 4.1B) is
concentrated at the axonal paranodes and juxtaparanodal re-
gion (Ohara et al., 2000; Poliak et al., 2001). A previous
study showed that the cytoplasmic domain of Caspr could
precipitate protein 4.1R from red blood cells and brain ly-
sates (Menegoz et al., 1997); however, a direct interaction be-
tween these two proteins was not demonstrated. Here, we ex-
tend these observations and show that Caspr physically
associates with protein 4.1B. This association is mediated by
a short juxtamembrane sequence (nine amino acids) present
in the cytoplasmic domain of Caspr, which shows strong
similarity to the protein 4.1R binding site found in erythro-
cyte glycophorin C (Marfatia et al., 1995). Furthermore, we
show that clustering of the Caspr–contactin complex on the
cell surface immobilized protein 4.1B into these clusters,
demonstrating that it is recruited to Caspr-containing sites
on the plasma membrane. Consistent with this notion, we
found that protein 4.1B was abnormally distributed along
peripheral myelinated axons of contactin-null mice, which
entirely lack the Caspr–contactin complex in their paranodes.
Mislocalization of protein 4.1B was also observed in galacto-
lipid-deficient mice, in which Caspr and contactin are dis-
placed from the paranodes and are occasionally detected
along the axon (Poliak et al., 2001). In these two paranodal
mutants, the position of protein 4.1B was strongly correlated
with the appearance of Caspr and Caspr2, suggesting that
both Caspr family members may regulate its localization in
myelinated axon. It was previously shown that neurexin-IV, a
 
Drosophila
 
 homologue of Caspr and Caspr2, associates with
and recruits the protein 4.1 homologue Coracle to the septate
junction (Baumgartner et al., 1996). However, in contrast to
the complete absence of Coracle from the septate junction in
 
neurexin IV
 
 mutants, in 
 
coracle
 
 mutants, neurexin IV still
reached the lateral membrane but was not subsequently con-
fined at the septate junction (Ward et al., 1998). These re-
sults indicate that although Coracle does not play a role in
the targeting of neurexin IV to the plasma membrane, it is re-
quired for its maintenance at the junction. In analogy, we
found that a deletion mutant of Caspr that lacks its intracel-
lular domain and is unable to bind protein 4.1B was targeted
to the paranodes, but was not maintained properly at the
junction. Because of the geometry of the myelinating cell, the
generation of the paranodal junction occurs gradually and
continues as additional loops are attached to the axon
(Rosenbluth, 1995). As a result, paranodal accumulation of
Caspr is composed of a number of rings that represent each
turn of the myelin warp and, thus, does not constitute a uni-
form domain. During myelination of dorsal root ganglion
neurons by Schwann cells in vitro, Caspr is detected in a spi-
ral corresponding to the overlying turn of the forming para-
nodal loop, which is later consolidated into a tight helical coil
(Pedraza et al., 2001). We have found no evidence for the ac-
cumulation of 4.1B with Caspr during this process, suggest-
ing that it may be recruited at a later stage when Caspr is al-
ready found at the paranodal junction. Taken together, it is
reasonable to suggest that during the generation of the para-
nodal junction, protein 4.1B is immobilized at Caspr-contain-
ing sites on the axolemma. This in turn may bridge the
Caspr–contactin complex to the rich cytoskeletal core present
at the axonal paranodes (Ichimura and Ellisman, 1991).
An important question is what determined the localiza-
tion of Caspr and Caspr2 in myelinating axons. Our obser-
vation that a Caspr mutant lacking the cytoplasmic domain
reaches the paranodal region argues against the possibility
that the cytoplasmic domains of Caspr and Caspr2 are re-
sponsible for their differential targeting and localization. In-
stead, these are more likely to be controlled by specific in-
teractions mediated by the distinct extracellular domains
of Caspr and Caspr2 (Poliak et al., 1999). Although
Caspr binds to contactin and indirectly to neurofascin 155
(Charles et al., 2002; unpublished data), found at the para-
nodal junction, Caspr2 does not interact with these mole-
cules, but may bind to TAG-1, a contactin family member
found at the juxtaparanodes (Traka et al., 2002). While un-
covering a role for the cytoplasmic domain of Caspr in
maintenance of the Caspr–contactin complex at the para-
nodes, our results do not exclude the possibility of an addi-
tional contribution of a glial ligand that binds the Caspr–
contactin complex in this process. Nevertheless, our results
raise the intriguing possibility that the chief function of
Caspr is to provide a “transmembrane scaffold” that stabi-
lizes the Caspr–contactin adhesion complex at the paranodal
junction by connecting it to cytoskeletal components within
the axon. This illustrates one mechanism by which the ax-
onal cytoskeleton cooperates with glial cues to organize
functional domains along myelinated axons.
 
Materials and methods
 
Constructs and transgenic mice
 
HA-tagged constructs were all generated from human Caspr cDNA using
PCR and standard cloning procedures. In CSP–HA, the HA tag (amino ac-
ids YPYDVPDYAS) was inserted at position 1385 after the carboxy-termi-
nal glutamic acid (E1384), whereas in CSPdCT–HA, it replaced the cyto-
plasmic sequence from the lysine at position 1312. These genes were
cloned into a Thy1.2 expression cassette (Caroni, 1997), linearized, and
introduced by pronuclear injection into fertilized eggs derived from CB6F1
mice. Pseudopregnant CD-1 outbreed albino females were used as foster
mothers for embryo transfer. Founder mice were genotyped by Southern
blot hybridization with a DNA fragment containing the first 730 bp of hu-
man Caspr. Founders were further crossed with CB6F1 mice and interbred
to generate lines. Transgenic mice were routinely identified by PCR of tail
genomic DNA, using the appropriate primers derived from human Caspr
cDNA and the HA tag. The same primers were also used for RT-PCR anal-
yses on RNAs prepared from mice brains. Myc tag protein 4.1B was gener-
ated by cloning the open reading of KIAA0987 downstream of a myc tag–
containing pCDNA3 vector (Invitrogen). For the generation of ConCT and
ConJXCT, the transmembrane and cytoplasmic domain of Caspr or a dele-
tion mutant lacking nine amino acids in the juxtamembrane region (Fig. 7)
were generated by PCR and attached after amino acid 1020 of human con-
tactin (Peles et al., 1995), replacing its GPI-linkage sequence.
 
Immunoprecipitation and immunoblot analysis
 
For preparation of mouse brain membranes, adult brains were homoge-
nized in a glass homogenizer in a buffer containing 20 mM Hepes, pH 7.4,
0.32 M sucrose, 1 mM EGTA, 1.5 mM MgSO
 
4
 
, 10 
 
 
 
g/ml aprotinin and leu-
peptin, and 1 mM PMSF. Nuclei and heavy cell debris were removed by
low speed centrifugation (3,000 
 
g
 
 for 10 min at 4
 
 
 
C), and the supernatants
were centrifuged at 40,000 
 
g
 
 for 60 min. Membrane pellets were solubi-
lized in Triton X-100 lysis buffer (Poliak et al., 1999) for 1 h on ice and then
the detergent-insoluble material was removed by centrifugation. Coimmu-
noprecipitation of Caspr and 4.1B was done using 14-wk-old rat brain ho-
mogenized in Triton X-100 lysis buffer (Poliak et al., 1999). For immuno-
precipitation, solubilized membrane supernatants were incubated with
antibodies coupled to Sepharose–protein A beads (Amersham Pharmacia
Biotech) or to agarose anti–mouse IgG beads (Sigma-Aldrich), followed by 
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Western blotting analyses using the ECL detection system (Amersham
Pharmacia Biotech) as previously described (Poliak et al., 1999). The anti-
bodies used, polyclonal antibody P6061 directed to the intracellular re-
gion of Caspr and monoclonal antibody M275 directed to its extracellular
domain, were previously described (Peles et al., 1997; Poliak et al., 1999).
Monoclonal antibody for Na
 
 
 
 channels was previously described (Ras-
band et al., 1999). Antibodies against HA tag and myc tag were purchased
from Boehringer and Santa Cruz Biotechnology, Inc. Polyclonal antibodies
against contactin were generated by immunization of rabbits with a puri-
fied human contactin–Ig fusion protein as described previously (Rios et al.,
2000). Polyclonal antibodies against protein 4.1B were generated by im-
munizing rabbits with a GST fusion protein containing amino acids
7-P778-L968 of human protein 4.1B (GenBank/EMBL/DDBJ accession no.
AB023204) according to Yamakawa et al., 2000. Removal of antibodies
against GST and affinity purification of the antibodies were performed as
described previously (Poliak et al., 1999).
 
Internalization assay
 
The internalization of ConCT and ConJXCT was analyzed by cell surface
biotinylation as previously described (Cao et al., 1998). HEK-293 cells sta-
bly expressing protein 4.1B were transfected with ConCT or ConJXCT. 48
h later, the cells were biotinylated with 0.5 mg/ml sulfo-NHS-
 
S
 
-
 
S
 
-biotin in
PBS for 30 min at 4
 
 
 
C. Excess biotin was removed by three washes with
TBS and the cells were then incubated in 37
 
 
 
C with DME containing 
 
 
 
C–
FC for various times to allow for endocytosis. Biotin attached to proteins
still remaining on the cell surface was stripped by washing the cells twice
with 50 mM glutathione in a buffer containing 75 mM NaCl, 75 mM
NaOH, and 10% FCS on ice. For each time point, a sample of cells not
treated with glutathione was used as a control. The cells were then incu-
bated twice for 15 min in buffer containing 50 mM iodoacetamide, 1%
BSA in PBS and further lysed with 1% Triton X-100 solubilization buffer
(Poliak et al., 1999). Biotinylated proteins were isolated from the superna-
tant using UltraLink immobilized NeutrAvidin beads (Pierce Chemical
Co.). Beads were washed three times with HNTG buffer (Poliak et al.,
1999), eluted with DTT-containing SDS-PAGE buffer, and subjected to
Western blotting using an anti–HA tag antibody.
 
Immunofluorescence
 
Tissues. 
 
Mouse optic nerves were isolated and directly frozen in O.C.T.
mounting medium (Tissue-Tek) and 10-
 
 
 
m sections were cut with a cryo-
stat. For sciatic nerve labeling experiments, nerves were isolated and
fixed for 10 min in Zamboni’s fixative, washed in PBS, and teased into sin-
gle fibers on gelatin-coated slides. Both optic and sciatic nerve prepara-
tions were then permeabilized for 20 min in cold methanol at 
 
 
 
20
 
 
 
C.
Slides were then washed with PBS, blocked for 30 min in PBS containing
10% goat serum, 1% glycine, and 0.1% Triton X-100 (PBTGG), and incu-
bated with first antibodies at the appropriate concentrations. After subse-
quent washes in PBS, the slides were reacted with Cy3- or Alexa
 
®
 
488-cou-
pled secondary antibodies obtained from Jackson ImmunoResearch
Laboratories or Molecular Probes and further processed as described previ-
ously (Poliak et al., 1999). Immunofluorescence slides were viewed and
analyzed using a Deltavision wide-field deconvolution microscope (Ap-
plied Precision), a Bio-Rad Laboratories confocal microscope, or a ZEISS
Axioplan microscope equipped with a SPOT-II (Diagnostic Instruments)
cooled CCD camera.
 
Cells. 
 
Cells seeded on glass slides were transfected using Lipofectamine
plus reagent (GIBCO BRL). 48 h later, cells were washed with PBS and fixed
in 4% paraformaldehyde for 15 min at room temperature. After washing
with PBS, the cells were incubated in blocking buffer either with (PBTGG)
or without 0.1% Triton X-100 (PBGG) for 30 min at ambient temperature.
Primary antibodies were diluted in either PBTGG or PBGG and incubated
for 2 h. After three washes with PBS, slides were incubated with secondary
antibodies for 45 min in DAPI-containing PBGG, subsequently washed
with PBS, mounted in elvanol, and analyzed as above. For clustering exper-
iments, cells were treated with DME containing 0.5–1 
 
 
 
g/ml 
 
 
 
C–Fc for 30
min at 4
 
 
 
C followed by three washes with cold DME on ice. Cells were fur-
ther incubated with Cy3-conjugated anti–human Fc (Jackson ImmunoRe-
search Laboratories) in DME containing 2% low IgG FCS (GIBCO BRL), 20
mM Hepes for 15 min at room temperature and then 15 min at 37
 
 
 
C. Un-
bound antibody was removed by three washes with PBS and the cells were
fixed with 4% paraformaldehyde. Nonclustered samples were fixed as
above before the incubation with the Cy3-conjugated anti–human Fc.
 
EM
 
Optic nerve tissues were fixed for 30 min in 4% paraformaldehyde, 0.1%
glutaraldehyde, 0.2% picric acid, and 5 mM CaCl
 
2
 
 in 0.1 M buffer caco-
 
dylate, pH 7.4. The tissue was then cut in to 1-mm segments. The samples
were further incubated in the same fixative for 2 h at 24 C and 10 h at 4 C.
After extensive washing with cacodylate buffer, the samples were cryopro-
tected by immersion for 5 min in 15% sucrose and 5% glycerol and 30
min in 30% sucrose and 10% glycerol and then frozen and thawed twice
in isopentane cooled in liquid nitrogen. Tissues were embedded in 7%
agar noble and cut at 50- m thickness using a vibrotome. Sections were
blocked for 1 h in 0.01% saponin (Sigma-Aldrich), 3% normal goat serum,
0.5% BSA, and 0.1% glycine in PBS. First antibodies were incubated over-
night in PBS containing 1% normal goat serum, 0.1% glycine, and 0.5%
BSA, extensively washed in PBS, and incubated with Nanogold 1:40 sec-
ondary antibodies (Nanoprobe). The sections were then washed and fixed
for 30 min as above and rinsed in distilled water before silver intensifica-
tion using HQ Silver (Nanoprobe). Samples were fixed in 3% glutaralde-
hyde, 3% paraformaldehyde, and 0.2% picric acid in cacodylate buffer
and then with 1% osmium tetraoxide, 0.5% potassium dichromate, and
0.5% potassium hexacyanoferrate. The tissue was postfixed with 2% aque-
ous uranyl acetate followed by ethanol dehydration and embedded in EM-
BED 812 (EMS). Sections were cut using a diamond knife (Diatome) and
examined using a Philips CM-12 transmission electron microscope at ac-
celerating voltage of 100 kV.
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